Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.2109
Abstract: Importance The risk of adverse events has been found to be low for participants receiving the BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna Inc) vaccines in randomized trials. However, a head-to-head comparison of their safety for a… read more here.
Keywords: bnt162b2 mrna; adverse events; vaccine; mrna 1273 ... See more keywords
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.17375
Abstract: This study evaluates the association between the AZD1222, BNT162b2, and mRNA-1273 vaccines and subsequent thromboembolic and thrombocytopenic events between 3 Nordic countries. read more here.
Keywords: nordic countries; mrna 1273; azd1222 bnt162b2; thromboembolic thrombocytopenic ... See more keywords
A prospective study on myocardial injury after BNT162b2 mRNA COVID‐19 fourth dose vaccination in healthy persons
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2687
Abstract: To prospectively evaluate the incidence of myocardial injury after the administration of the fourth dose BNT162b2 mRNA vaccine (Pfizer‐BioNTech) against COVID‐19. read more here.
Keywords: fourth dose; bnt162b2 mrna; prospective study; myocardial injury ... See more keywords
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
Sign Up to like & getrecommendations! Published in 2021 at "Cell Reports"
DOI: 10.1016/j.celrep.2021.109504
Abstract: Early responses to vaccination are important in shaping both humoral and cellular protective immunity. Dissecting innate vaccine signatures may predict immunogenicity to help optimizing efficacy of mRNA and other vaccine strategies. We characterized the cytokine… read more here.
Keywords: response; vaccine; mrna vaccine; ifn cxcl10 ... See more keywords
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2021.07.031
Abstract: Objectives The immunogenicity and safety of the Pfizer-BioNTech BNT162b2 mRNA vaccine in people living with HIV-1 (PLWH) are unknown. We thus aimed to assess the immunogenicity and safety of this vaccine in PLWH. Methods In… read more here.
Keywords: vaccine people; vaccine; immunogenicity safety; bnt162b2 mrna ... See more keywords
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2021.09.006
Abstract: Objectives To investigate the immune systems’ response (and its influencing factors) to vaccination with BNT162b2 or mRNA-1273. Methods 531 vaccinees, recruited from health care professionals, donated samples before, in between, and after the administration of… read more here.
Keywords: response; mrna 1273; sars cov; bnt162b2 mrna ... See more keywords
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
Sign Up to like & getrecommendations! Published in 2021 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2021.101158
Abstract: Background Trials of the Pfizer-BioNTech BNT162b2 mRNA vaccine showed 95% efficacy in preventing symptomatic disease; however, the trials excluded immunocompromised patients (ICPs). We aim at analyzing antibody response in ICPs. Methods A prospective cohort study… read more here.
Keywords: prospective cohort; response; bnt162b2 mrna; vaccine ... See more keywords
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Cardiology"
DOI: 10.1016/j.ijcard.2021.08.018
Abstract: Immune-mediated myocardial injury following Severe Acute Respiratory Syndrome Coronavirys-2 (SARS-CoV2) infection has been described in adults and children. Cases of myocarditis following immunization for SARS-CoV2 have recently been documented, mostly associated with mild severity and… read more here.
Keywords: covid vaccination; mrna covid; fulminant myocarditis; bnt162b2 mrna ... See more keywords
Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Infectious Diseases"
DOI: 10.1016/j.ijid.2021.04.047
Abstract: Introduction Concerns are prevailing about the safety and side effects from BNT162b2 mRNA COVID-19 vaccine. Methods A randomized, cross-sectional study was performed to investigate the side effects of BNT162b2 vaccine using an independent online questionnaire… read more here.
Keywords: covid vaccine; mrna covid; effects bnt162b2; bnt162b2 mrna ... See more keywords
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.
Sign Up to like & getrecommendations! Published in 2021 at "Nature medicine"
DOI: 10.1038/s41591-021-01542-z
Abstract: Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have shown high efficacy, but immunocompromised participants were excluded from controlled clinical trials. In this study, we compared immune responses to the BNT162b2 mRNA Coronavirus Disease… read more here.
Keywords: solid tumors; immune responses; patients cancer; bnt162b2 mrna ... See more keywords
COVID-19 BNT162b2 mRNA vaccine induced myocarditis with left ventricular thrombus in a young male
Sign Up to like & getrecommendations! Published in 2023 at "Acta Cardiologica"
DOI: 10.1080/00015385.2023.2165271
Abstract: A 20-year-old man presented with chest pain started on the 3th day of his first dose of mRNA coronavirus disease 2019 (COVID-19) Vaccine (BNT162b2). On presentation, the patient’s temperature was 37.6 C, blood pressure was… read more here.
Keywords: mrna vaccine; covid bnt162b2; covid; bnt162b2 mrna ... See more keywords